Showing results (121-130 of 254) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care PerspectiveKemal C Gogebakan, Natalia Kunst, Alireza Ghodsi, et al.
Statistical Applications in Genetics and Molecular Biology|October 20, 2006
Combining results of microarray experiments: a rank aggregation approachRobert P DeConde, Sarah Hawley, Seth Falcon, et al.
Journal of Cancer Survivorship : Research and Practice|April 14, 2021
Identifying breast cancer recurrence histories via patient-reported outcomesJ David Beatty, Qin Sun, Daniel Markowitz, et al.
Journal of the National Cancer Institute|January 9, 2014
Individualized estimates of overdiagnosis in screen-detected prostate cancerRoman Gulati, Lurdes Y T Inoue, John L Gore, et al.
Biometrics|August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific timeStuart G Baker, Daniel J Sargent, Marc Buyse, et al.
Journal of Clinical Epidemiology|September 2, 2024
Surrogate endpoint metaregression: useful statistics for regulators and trialistsStuart G Baker, Marissa N D Lassere, Wang Pok Lo
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2009
Effect of population trends in body mass index on prostate cancer incidence and mortality in the United StatesMegan Dann Fesinmeyer, Roman Gulati, Steve Zeliadt, et al.
Urology|December 15, 2004
Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999Steven B Zeliadt, Arnold L Potosky, Ruth Etzioni, et al.
Journal of the National Cancer Institute|November 9, 2023
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologiesRuth Etzioni, Roman Gulati, Christos Patriotis, et al.
Plos One|February 15, 2019
A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry dataAndreas Karlsson, Alexandra Jauhiainen, Roman Gulati, et al.
Pageof 26